Entact Bio Funding: $81M Raised, Series A (2022)

Entact Bio funding overview

Entact Bio is based in Watertown. Entact Bio has raised $81M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2022. The round record for Entact Bio runs through 2022; nothing later has been disclosed. Investors on record include Qiming Venture Partners USA, venBio Partners, Abingworth, Brandon Capital, Janus Henderson Investors, Logos Global Management, LP and 4 others. 10 distinct backers are named across the disclosed rounds.

Entact Bio at a glance

Total raised: $81M
Latest round: Series A
Latest round date: December 2022
Headquarters: Watertown
Notable investors: Qiming Venture Partners USA, venBio Partners, Abingworth, Brandon Capital, Janus Henderson Investors, Logos Global Management, LP, Surveyor Capital, WEHI

Frequently asked about Entact Bio funding

How much has Entact Bio raised?: Entact Bio has raised $81M in total disclosed funding across the rounds on record.
Who has invested in Entact Bio?: Qiming Venture Partners USA, venBio Partners, Abingworth, Brandon Capital, Janus Henderson Investors, Logos Global Management, LP are named among the investors backing Entact Bio.
What was the latest Entact Bio funding round?: The most recent disclosed round is a Series A, announced in December 2022.
Where is Entact Bio based?: Entact Bio is based in Watertown.
When did Entact Bio last raise?: The last disclosed Entact Bio round closed in December 2022 at Series A.

Every Entact Bio figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Watertown at a similar stage.

Entact Bio Funding: $81M Raised, Series A (2022)

Entact Bio funding overview

Entact Bio at a glance

Frequently asked about Entact Bio funding

Companies related to Entact Bio (31)

Browse related funding lists (8)